AstraZeneca Genomics on AWS: A Journey from Petabytes to New Medicines

1 785
19.2
Опубликовано 27 января 2021, 23:51
AstraZeneca is on a mission to analyze 2 million genomes/exomes by 2026 for integration with clinical data and use in R&D, clinical trials, and stratified medicine. To achieve this milestone, AstraZeneca built a world-leading genomics pipeline using high performance computing technologies such as AWS Batch and AWS Step Functions that is capable of processing more than 1,600 exomes per hour.

To learn more about how the BioPharma industry builds on AWS, visit: amzn.to/3ppOPRz

Subscribe:
More AWS videos - bit.ly/2O3zS75
More AWS events videos - bit.ly/316g9t4

#AWS
автотехномузыкадетское